NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY) Stock Information | RedChip

NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY)


$0.6110
-0.0315 ( -8.26% ) 35.7K

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Market Data


Open


$0.6110

Previous close


$0.6425

Volume


35.7K

Market cap


$3.13M

Day range


$0.6080 - $0.6800

52 week range


$0.3611 - $9.0790

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 Dec 19, 2024
8-k 8K-related 16 Nov 22, 2024
10-q Quarterly Reports 94 Nov 07, 2024
8-k 8K-related 17 Nov 06, 2024
8-k 8K-related 16 Oct 29, 2024
8-k 8K-related 14 Oct 16, 2024
prem14a Proxies and info statements 8 Sep 25, 2024
8-k 8K-related 18 Sep 20, 2024
10-q Quarterly Reports 95 Aug 13, 2024
8-k 8K-related 23 Jul 29, 2024

Latest News